Obesity Affects HDL Metabolism, Composition and Subclass Distribution

Background: Obesity increases the risk of coronary heart disease, partly due to its strong association with atherogenic dyslipidemia, characterized by high triglycerides and low high-density lipoprotein (HDL) cholesterol levels. Functional impairment of HDL may contribute to the increased cardiovascular mortality, but the effect of obesity on composition, structure, and function of HDL is not well understood. Design and Methods: We determined HDL composition, HDL subclass distribution, parameters of HDL function, and activities of most important enzymes involved in lipoprotein remodeling, including lecithin–cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP) in relatively young normal weight (n = 26), overweight (n = 22), and obese (n = 20) women. Results: Obesity (body mass index (BMI) ≥ 30) was associated with noticeable changes in LCAT and CETP activities and altered HDL composition, such as decreased apolipoprotein A-I, cholesterol, and phospholipid content, while pro-inflammatory HDL serum amyloid a content was increased. We observed a marked shift towards smaller HDL subclasses in obesity linked to lower anti-oxidative capacity of serum. LCAT activity, HDL subclass distribution, and HDL-cholesterol were associated with soluble leptin receptor, adiponectin, and liver enzyme activities. Of note, most of these alterations were only seen in obese women but not in overweight women. Conclusions: Obesity markedly affects HDL metabolism, composition, and subclass distribution linked to changes in liver and adipose tissue. HDL dysfunction may contribute to increased cardiovascular risk in obesity.

[1]  B. Nordestgaard,et al.  VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins. , 2020, Journal of the American College of Cardiology.

[2]  G. Marsche,et al.  Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function , 2020, International journal of molecular sciences.

[3]  G. Heine,et al.  Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease , 2020, Biomolecules.

[4]  G. Norata,et al.  Low Plasma Lecithin: Cholesterol Acyltransferase (LCAT) Concentration Predicts Chronic Kidney Disease , 2020, Journal of clinical medicine.

[5]  Daniel M. Rotroff,et al.  Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes , 2020, Biomolecules.

[6]  H. Scharnagl,et al.  HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure. , 2020, Journal of hepatology.

[7]  R. Santos,et al.  Free cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular disease , 2019, European journal of preventive cardiology.

[8]  M. Lehofer,et al.  Novel approaches for the assessment of relative body weight and body fat in diagnosis and treatment of anorexia nervosa: A cross-sectional study. , 2019, Clinical nutrition.

[9]  G. Sturm,et al.  Allergic rhinitis is associated with complex alterations in high-density lipoprotein composition and function. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[10]  J. Goedecke,et al.  HDL Subclass Distribution Shifts with Increasing Central Adiposity , 2019, Journal of obesity.

[11]  W. Weger,et al.  Abnormal composition and function of high‐density lipoproteins in atopic dermatitis patients , 2018, Allergy.

[12]  Raiya Sarwar,et al.  Obesity and nonalcoholic fatty liver disease: current perspectives , 2018, Diabetes, metabolic syndrome and obesity : targets and therapy.

[13]  M. Lehofer,et al.  Gut microbiota, dietary intakes and intestinal permeability reflected by serum zonulin in women , 2018, European Journal of Nutrition.

[14]  C. Drevon,et al.  Soluble Leptin Receptor Predicts Insulin Sensitivity and Correlates With Upregulation of Metabolic Pathways in Men , 2017, The Journal of clinical endocrinology and metabolism.

[15]  G. Gorkiewicz,et al.  Gut microbiota and body composition in anorexia nervosa inpatients in comparison to athletes, overweight, obese, and normal weight controls , 2017, The International journal of eating disorders.

[16]  G. Pregartner,et al.  Adiponectin Predicts High‐Density Lipoprotein Cholesterol Efflux Capacity in Adults Irrespective of Body Mass Index and Fat Distribution , 2017, The Journal of clinical endocrinology and metabolism.

[17]  A. Kontush,et al.  Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit , 2017, BBA clinical.

[18]  T. Berg,et al.  Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality , 2017, BMC Gastroenterology.

[19]  N. Bachl,et al.  Standardized Ultrasound Measurement of Subcutaneous Fat Patterning: High Reliability and Accuracy in Groups Ranging from Lean to Obese. , 2017, Ultrasound in medicine & biology.

[20]  R. Birner-Gruenberger,et al.  Liver disease alters high-density lipoprotein composition, metabolism and function , 2016 .

[21]  L. Opie,et al.  Association between ethnicity and obesity with high-density lipoprotein (HDL) function and subclass distribution , 2016, Lipids in Health and Disease.

[22]  P. Scherer,et al.  Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. , 2016, Cell metabolism.

[23]  T. Lohman,et al.  Subcutaneous fat patterning in athletes: selection of appropriate sites and standardisation of a novel ultrasound measurement technique: ad hoc working group on body composition, health and performance, under the auspices of the IOC Medical Commission , 2015, British Journal of Sports Medicine.

[24]  K. Rye,et al.  HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. , 2015, Circulation research.

[25]  H. Scharnagl,et al.  Dialysis Modalities and HDL Composition and Function. , 2015, Journal of the American Society of Nephrology : JASN.

[26]  L. Rohrer,et al.  Rapid and Body Weight–Independent Improvement of Endothelial and High-Density Lipoprotein Function After Roux-en-Y Gastric Bypass: Role of Glucagon-Like Peptide-1 , 2015, Circulation.

[27]  A. Khera,et al.  HDL cholesterol efflux capacity and incident cardiovascular events. , 2014, The New England journal of medicine.

[28]  A. S. Al-Goblan,et al.  Mechanism linking diabetes mellitus and obesity , 2014, Diabetes, metabolic syndrome and obesity : targets and therapy.

[29]  A. Kontush HDL-mediated mechanisms of protection in cardiovascular disease. , 2014, Cardiovascular research.

[30]  Deepak L. Bhatt,et al.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. , 2014, The New England journal of medicine.

[31]  M. Zaki,et al.  Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents , 2014, Indian journal of endocrinology and metabolism.

[32]  Kazuto Nakamura,et al.  Adipokines: a link between obesity and cardiovascular disease. , 2014, Journal of cardiology.

[33]  D. Kiortsis,et al.  Adiponectin and lipoprotein metabolism , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[34]  E. Fisher,et al.  Lipoprotein Metabolism, Dyslipidemia, and Nonalcoholic Fatty Liver Disease , 2013, Seminars in Liver Disease.

[35]  G. De Pergola,et al.  Obesity as a Major Risk Factor for Cancer , 2013, Journal of obesity.

[36]  L. Aronne,et al.  Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. , 2013, Journal of clinical lipidology.

[37]  M. Garelnabi,et al.  Antioxidant and Anti-Inflammatory Role of Paraoxonase 1: Implication in Arteriosclerosis Diseases , 2012, North American journal of medical sciences.

[38]  Meinrad Lindschinger,et al.  Oxidative stress increases continuously with BMI and age with unfavourable profiles in males , 2012, The aging male : the official journal of the International Society for the Study of the Aging Male.

[39]  R. Dullaart,et al.  Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL , 2012, European journal of clinical investigation.

[40]  A. Kontush,et al.  Biological activities of HDL subpopulations and their relevance to cardiovascular disease. , 2011, Trends in molecular medicine.

[41]  J. S. Elmendorf,et al.  Evidence That Chromium Modulates Cellular Cholesterol Homeostasis and ABCA1 Functionality Impaired by Hyperinsulinemia—Brief Report , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[42]  D. Rader,et al.  Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents. , 2011, The Journal of clinical endocrinology and metabolism.

[43]  J. Tanabe,et al.  Insulin suppresses HDL-mediated cholesterol efflux from macrophages through inhibition of neutral cholesteryl ester hydrolase and ATP-binding cassette transporter G1 expressions. , 2010, Journal of atherosclerosis and thrombosis.

[44]  A. Tall Functions of cholesterol ester transfer protein and relationship to coronary artery disease risk. , 2010, Journal of clinical lipidology.

[45]  L. Bajnok,et al.  Human Paraoxonase-1 Activity in Childhood Obesity and Its Relation to Leptin and Adiponectin Levels , 2010, Pediatric Research.

[46]  J. Frystyk,et al.  Adiponectin and Lipoprotein Particle Size , 2009, Diabetes Care.

[47]  S. Kihara,et al.  Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver. , 2008, FEBS letters.

[48]  D. Rader,et al.  Obesity and atherogenic dyslipidemia. , 2007, Gastroenterology.

[49]  J. Griffin,et al.  Endothelial and antithrombotic actions of HDL. , 2006, Circulation research.

[50]  Thomas D. Giles,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[51]  J. Schneider,et al.  Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. , 2005, Diabetes care.

[52]  Stephan Rössner,et al.  Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: executive summary. , 2004, Circulation.

[53]  P. Barter,et al.  Antiinflammatory Properties of HDL , 2004 .

[54]  Charles C Schwartz,et al.  Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300511-JLR200 , 2004, Journal of Lipid Research.

[55]  T. Saruta,et al.  Relationships between serum soluble leptin receptor level and serum leptin and adiponectin levels, insulin resistance index, lipid profile, and leptin receptor gene polymorphisms in the Japanese population. , 2004, Metabolism: clinical and experimental.

[56]  B. Howard,et al.  Obesity and dyslipidemia. , 2003, Endocrinology and metabolism clinics of North America.

[57]  R. Dullaart,et al.  Alterations in high‐density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins , 2003, European journal of clinical investigation.

[58]  F. Tatzber,et al.  Dual method for the determination of peroxidase activity and total peroxides-iodide leads to a significant increase of peroxidase activity in human sera. , 2003, Analytical biochemistry.

[59]  R. Lüdtke,et al.  Effects of One Week Juice Fasting on Lipid Metabolism: A Cohort Study in Healthy Subjects , 2003, Complementary Medicine Research.

[60]  S. Kaser,et al.  Relationship Between Cholesteryl Ester Transfer Protein and Atherogenic Lipoprotein Profile in Morbidly Obese Women , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[61]  T. Saruta,et al.  Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. , 2002, Clinical science.

[62]  A. Jonas,et al.  Binding affinity and reactivity of lecithin cholesterol acyltransferase with native lipoproteins. , 1999, Biochemical and biophysical research communications.

[63]  J. Frohlich,et al.  Understanding the mechanism of LCAT reaction may help to explain the high predictive value of LDL/HDL cholesterol ratio. , 1998, Physiological research.

[64]  M. McDonnell,et al.  Cholesteryl ester transfer protein (CETP) mRNA abundance in human adipose tissue: relationship to cell size and membrane cholesterol content. , 1995, Journal of lipid research.

[65]  G. Franceschini,et al.  Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[66]  R. Mahley,et al.  Plasma lipoproteins: apolipoprotein structure and function. , 1984, Journal of lipid research.

[67]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[68]  W. Brown,et al.  Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. , 1972, Biochemical and biophysical research communications.

[69]  J. Glomset,et al.  The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.